We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

132 hedge funds and large institutions have $484M invested in Albany Molecular Research Inc in 2014 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 50 increasing their positions, 39 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more call options, than puts

Call options by funds: $3.57M | Put options by funds: $1.19M

28% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 39

8% less funds holding

Funds holding: 143132 (-11)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

28% less capital invested

Capital invested by funds: $669M → $484M (-$185M)

33% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 30

Holders
132
Holders Change
-11
Holders Change %
-7.69%
% of All Funds
3.52%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
20
Increased
50
Reduced
39
Closed
30
Calls
$3.57M
Puts
$1.19M
Net Calls
+$2.38M
Net Calls Change
+$1.48M
Name Holding Trade Value Shares
Change
Change in
Stake
Prudential Financial
51
Prudential Financial
New Jersey
$864K +$12.8K +700 +1%
SO
52
STRS Ohio
Ohio
$796K +$281K +15,300 +46%
Comerica Bank
53
Comerica Bank
Texas
$760K +$431K +23,509 +101%
Public Sector Pension Investment Board (PSP Investments)
54
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$721K
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
$711K +$3.41K +186 +0.4%
RIM
56
Ranger Investment Management
Texas
$709K +$233K +12,710 +41%
New York State Common Retirement Fund
57
New York State Common Retirement Fund
New York
$698K +$112K +6,100 +17%
Charles Schwab
58
Charles Schwab
California
$684K
FQ
59
First Quadrant
California
$646K
AQR Capital Management
60
AQR Capital Management
Connecticut
$640K -$338K -18,442 -32%
RhumbLine Advisers
61
RhumbLine Advisers
Massachusetts
$635K +$13.4K +730 +2%
TA
62
Teachers Advisors
New York
$541K
Royal Bank of Canada
63
Royal Bank of Canada
Ontario, Canada
$536K
BCM
64
Bridgeway Capital Management
Texas
$533K
KeyBank National Association
65
KeyBank National Association
Ohio
$505K
SCA
66
STALEY CAPITAL ADVISERS
Pennsylvania
$488K
AllianceBernstein
67
AllianceBernstein
Tennessee
$476K +$35.8K +1,950 +7%
Swiss National Bank
68
Swiss National Bank
Switzerland
$449K
ProShare Advisors
69
ProShare Advisors
Maryland
$442K +$10.5K +571 +2%
WIC
70
Woodmont Investment Counsel
Tennessee
$420K -$239K -13,023 -34%
Tudor Investment Corp
71
Tudor Investment Corp
Connecticut
$394K +$146K +7,945 +49%
CSS
72
Cubist Systematic Strategies
Connecticut
$387K +$437K +23,800 New
D.E. Shaw & Co
73
D.E. Shaw & Co
New York
$384K +$433K +23,577 New
LBC
74
Lawrence B. Cohen
$353K
TPSF
75
Texas Permanent School Fund
Texas
$349K +$73 +4 +0%

AMRI Hedge Fund Activity: Q4 2014 in Review

132 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q4 2014, worth a combined $484M — down 28% from $669M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of AMRI and 20 opened new positions — a net loss of 10 holders — while 39 trimmed existing stakes and 50 added.

The largest buyer was Visium Asset Management, adding an estimated $36.7M. The largest seller was Morgan Stanley, cutting an estimated $19.3M.

  • 132 institutional investors held Albany Molecular Research Inc (AMRI) as of Q4 2014, down from 143 in Q3 2014.
  • Funds reported $484M of Albany Molecular Research Inc stock for Q4 2014, down 28% quarter-over-quarter.
  • 20 funds opened new Albany Molecular Research Inc positions in Q4 2014 and 30 closed out, a net change of -10 holders.
  • The largest Albany Molecular Research Inc buyer in Q4 2014 was Visium Asset Management, an estimated $36.7M added.
  • The largest Albany Molecular Research Inc seller in Q4 2014 was Morgan Stanley, an estimated $19.3M sold.

Based on aggregated 13F filings for Q4 2014.